These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12862363

  • 1. Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Ichimura S, Uzawa M.
    Keio J Med; 2003 Jun; 52(2):113-9. PubMed ID: 12862363
    [Abstract] [Full Text] [Related]

  • 2. Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Yonsei Med J; 2005 Dec 31; 46(6):750-8. PubMed ID: 16385649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Clin Rheumatol; 2004 Oct 31; 23(5):383-9. PubMed ID: 15278749
    [Abstract] [Full Text] [Related]

  • 6. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    J Bone Miner Metab; 2005 Oct 31; 23(3):238-42. PubMed ID: 15838627
    [Abstract] [Full Text] [Related]

  • 7. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
    Sahota O, Fowler I, Blackwell PJ, Lawson N, Cawte SA, San P, Masud T, Hosking DJ.
    Osteoporos Int; 2000 Oct 31; 11(11):959-66. PubMed ID: 11193249
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures.
    Iwamoto J, Takeda T, Ichimura S, Uzawa M.
    Keio J Med; 2003 Dec 31; 52(4):230-5. PubMed ID: 14748475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
    Yamazaki S, Ichimura S, Iwamoto J, Takeda T, Toyama Y.
    J Bone Miner Metab; 2004 Dec 31; 22(5):500-8. PubMed ID: 15316873
    [Abstract] [Full Text] [Related]

  • 11. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
    Watts NB, Becker P.
    Bone; 1999 Jan 31; 24(1):65-8. PubMed ID: 9916786
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.
    Cortet B, Béra-Louville A, Gauthier P, Gauthier A, Marchandise X, Delcambre B.
    Joint Bone Spine; 2001 Oct 31; 68(5):410-5. PubMed ID: 11707007
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Response to alendronate in osteoporosis after previous treatment with etidronate.
    Fairney A, Kyd P, Thomas E, Wilson J.
    Osteoporos Int; 2000 Oct 31; 11(7):621-5. PubMed ID: 11069197
    [Abstract] [Full Text] [Related]

  • 15. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
    Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH.
    Am J Med; 1997 Dec 31; 103(6):468-76. PubMed ID: 9428829
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ.
    Am J Med; 1998 Mar 31; 104(3):219-26. PubMed ID: 9552083
    [Abstract] [Full Text] [Related]

  • 20. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T, McGuigan L, Barbagallo S, Bryant C.
    Am J Med; 1995 May 31; 98(5):459-63. PubMed ID: 7733124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.